SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA, a leading global provider of pharmaceutical packaging solutions, is headquartered in Germany. Established in 1884, the company has evolved into a key player in the pharmaceutical and healthcare industries, with significant operations across Europe, North America, and Asia. Specialising in high-quality glass and polymer packaging, SCHOTT Pharma offers a diverse range of products, including vials, syringes, and ampoules, designed to ensure the safety and efficacy of medications. Their commitment to innovation and sustainability sets them apart in a competitive market. With a strong focus on customer-centric solutions, SCHOTT Pharma has achieved notable milestones, including advancements in drug delivery systems and a robust portfolio that caters to the evolving needs of the pharmaceutical sector. Their reputation for excellence positions them as a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does SCHOTT Pharma AG & Co. KGaA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Glass Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SCHOTT Pharma AG & Co. KGaA's score of 34 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SCHOTT Pharma AG & Co. KGaA's reported carbon emissions
In 2023, SCHOTT Pharma AG & Co. KGaA reported total carbon emissions of approximately 30226000 kg CO2e for Scope 1 and about 43587000 kg CO2e for Scope 2. The company's Scope 3 emissions were significantly higher, totalling around 418000000 kg CO2e, with major contributions from purchased goods and services (approximately 227000000 kg CO2e) and capital goods (about 48000000 kg CO2e). For 2024, emissions data indicates a slight reduction in Scope 1 emissions to about 27536000 kg CO2e and a marginal increase in Scope 2 emissions to approximately 43941000 kg CO2e. Scope 3 emissions also decreased to around 398000000 kg CO2e. Despite these figures, SCHOTT Pharma has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of defined reduction strategies suggests a need for further engagement in climate action within the pharmaceutical industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 30,226,000 | 00,000,000 |
| Scope 2 | 43,587,000 | 00,000,000 |
| Scope 3 | 418,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SCHOTT Pharma AG & Co. KGaA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
